Bessemer Venture Partners: Direct-to-clinician—How product-led growth is changing healthcare and life sciences

September 28, 2022 -- Atropos Health is featured in a piece on “the new DTC - Direct to Clinician” by Morgan Cheatham at Bessemer Venture Partners.

It’s a compelling assessment - check out the full text here & key highlights below.

“As our current corpus of medical knowledge doubles every 73 days, it’s not feasible for practitioners to retain every detail. Software and AI are well-suited to supercharge clinical workforces via next-generation clinical decision support (CDS) tools and computational diagnostics… 

Building upon foundational resources like UpToDate and Epocrates, next-generation CDS tools are personalized and leverage advanced computational methods to inform clinical decisions. For example, Atropos Health, a physician consultation service powered by publication-grade real-world evidence studies called “prognostograms,” leverages millions of anonymized patient records, coupled with a powerful querying language, to empower physicians to answer highly specific questions pertaining to patients under their care. (You can order a prognostogram here!)

…ultimately, there has never been a more important time than now to empower healthcare and life science workers to do their best, most efficient work. Luckily, there’s a new wave of innovators who are building the tools to unlock unprecedented advances in the healthcare and life sciences field.”

Atropos Health’s clinical informatics consult service on Bessemer’s market map for product-led growth in healthcare and life sciences.